0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Therapeutic Radiopharmaceuticals Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-8K14324
Home | Market Reports | Health| Pharmacy
Global Therapeutic Radiopharmaceuticals Market Research Report 2023
BUY CHAPTERS

Global Therapeutic Radiopharmaceuticals Market Research Report 2024

Code: QYRE-Auto-8K14324
Report
January 2024
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Therapeutic Radiopharmaceuticals Market Size

The global Therapeutic Radiopharmaceuticals market was valued at US$ 1771 million in 2023 and is anticipated to reach US$ 4734 million by 2030, witnessing a CAGR of 15.1% during the forecast period 2024-2030.

Therapeutic Radiopharmaceuticals Market

Therapeutic Radiopharmaceuticals Market

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Radiopharmaceuticals.

Report Scope

The Therapeutic Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Therapeutic Radiopharmaceuticals Market Report

Report Metric Details
Report Name Therapeutic Radiopharmaceuticals Market
Accounted market size in 2023 US$ 1771 million
Forecasted market size in 2030 US$ 4734 million
CAGR 15.1%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Radium-223
  • Lutetium-177
  • Iodine-131
  • Other
Segment by Application
  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus, Aurobindo Pharma, International Isotopes, Mundipharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Therapeutic Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Therapeutic Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Therapeutic Radiopharmaceuticals Market growing?

Ans: The Therapeutic Radiopharmaceuticals Market witnessing a CAGR of 15.1% during the forecast period 2024-2030.

What is the Therapeutic Radiopharmaceuticals Market size in 2030?

Ans: The Therapeutic Radiopharmaceuticals Market size in 2030 will be US$ 4734 million.

Who are the main players in the Therapeutic Radiopharmaceuticals Market report?

Ans: The main players in the Therapeutic Radiopharmaceuticals Market are Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus, Aurobindo Pharma, International Isotopes, Mundipharma

What are the Application segmentation covered in the Therapeutic Radiopharmaceuticals Market report?

Ans: The Applications covered in the Therapeutic Radiopharmaceuticals Market report are Thyroid, Bone Metastasis, Lymphoma, Other

What are the Type segmentation covered in the Therapeutic Radiopharmaceuticals Market report?

Ans: The Types covered in the Therapeutic Radiopharmaceuticals Market report are Radium-223, Lutetium-177, Iodine-131, Other

1 Therapeutic Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of Therapeutic Radiopharmaceuticals
1.2 Therapeutic Radiopharmaceuticals Segment by Type
1.2.1 Global Therapeutic Radiopharmaceuticals Market Value Comparison by Type (2024-2030)
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Therapeutic Radiopharmaceuticals Segment by Application
1.3.1 Global Therapeutic Radiopharmaceuticals Market Value by Application: (2024-2030)
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Global Therapeutic Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Radiopharmaceuticals Revenue 2019-2030
1.4.2 Global Therapeutic Radiopharmaceuticals Sales 2019-2030
1.4.3 Global Therapeutic Radiopharmaceuticals Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Therapeutic Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global Therapeutic Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
2.2 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Therapeutic Radiopharmaceuticals Average Price by Manufacturers (2019-2024)
2.4 Global Therapeutic Radiopharmaceuticals Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Therapeutic Radiopharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Therapeutic Radiopharmaceuticals, Product Type & Application
2.7 Therapeutic Radiopharmaceuticals Market Competitive Situation and Trends
2.7.1 Therapeutic Radiopharmaceuticals Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Therapeutic Radiopharmaceuticals Players Market Share by Revenue
2.7.3 Global Therapeutic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Therapeutic Radiopharmaceuticals Retrospective Market Scenario by Region
3.1 Global Therapeutic Radiopharmaceuticals Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Therapeutic Radiopharmaceuticals Global Therapeutic Radiopharmaceuticals Sales by Region: 2019-2030
3.2.1 Global Therapeutic Radiopharmaceuticals Sales by Region: 2019-2024
3.2.2 Global Therapeutic Radiopharmaceuticals Sales by Region: 2025-2030
3.3 Global Therapeutic Radiopharmaceuticals Global Therapeutic Radiopharmaceuticals Revenue by Region: 2019-2030
3.3.1 Global Therapeutic Radiopharmaceuticals Revenue by Region: 2019-2024
3.3.2 Global Therapeutic Radiopharmaceuticals Revenue by Region: 2025-2030
3.4 North America Therapeutic Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 North America Therapeutic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Therapeutic Radiopharmaceuticals Sales by Country (2019-2030)
3.4.3 North America Therapeutic Radiopharmaceuticals Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Therapeutic Radiopharmaceuticals Market Facts & Figures by Country
3.5.1 Europe Therapeutic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Therapeutic Radiopharmaceuticals Sales by Country (2019-2030)
3.5.3 Europe Therapeutic Radiopharmaceuticals Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Asia Pacific Therapeutic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Therapeutic Radiopharmaceuticals Sales by Country (2019-2030)
3.6.3 Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Therapeutic Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America Therapeutic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Therapeutic Radiopharmaceuticals Sales by Country (2019-2030)
3.7.3 Latin America Therapeutic Radiopharmaceuticals Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Therapeutic Radiopharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Country (2019-2030)
3.8.3 Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Therapeutic Radiopharmaceuticals Sales by Type (2019-2030)
4.1.1 Global Therapeutic Radiopharmaceuticals Sales by Type (2019-2024)
4.1.2 Global Therapeutic Radiopharmaceuticals Sales by Type (2025-2030)
4.1.3 Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2019-2030)
4.2 Global Therapeutic Radiopharmaceuticals Revenue by Type (2019-2030)
4.2.1 Global Therapeutic Radiopharmaceuticals Revenue by Type (2019-2024)
4.2.2 Global Therapeutic Radiopharmaceuticals Revenue by Type (2025-2030)
4.2.3 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
4.3 Global Therapeutic Radiopharmaceuticals Price by Type (2019-2030)
5 Segment by Application
5.1 Global Therapeutic Radiopharmaceuticals Sales by Application (2019-2030)
5.1.1 Global Therapeutic Radiopharmaceuticals Sales by Application (2019-2024)
5.1.2 Global Therapeutic Radiopharmaceuticals Sales by Application (2025-2030)
5.1.3 Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2019-2030)
5.2 Global Therapeutic Radiopharmaceuticals Revenue by Application (2019-2030)
5.2.1 Global Therapeutic Radiopharmaceuticals Revenue by Application (2019-2024)
5.2.2 Global Therapeutic Radiopharmaceuticals Revenue by Application (2025-2030)
5.2.3 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
5.3 Global Therapeutic Radiopharmaceuticals Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Therapeutic Radiopharmaceuticals Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Therapeutic Radiopharmaceuticals Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 China Isotope & Radiation
6.3.1 China Isotope & Radiation Corporation Information
6.3.2 China Isotope & Radiation Description and Business Overview
6.3.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.3.4 China Isotope & Radiation Therapeutic Radiopharmaceuticals Product Portfolio
6.3.5 China Isotope & Radiation Recent Developments/Updates
6.4 Dongcheng
6.4.1 Dongcheng Corporation Information
6.4.2 Dongcheng Description and Business Overview
6.4.3 Dongcheng Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dongcheng Therapeutic Radiopharmaceuticals Product Portfolio
6.4.5 Dongcheng Recent Developments/Updates
6.5 Q BioMed
6.5.1 Q BioMed Corporation Information
6.5.2 Q BioMed Description and Business Overview
6.5.3 Q BioMed Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Q BioMed Therapeutic Radiopharmaceuticals Product Portfolio
6.5.5 Q BioMed Recent Developments/Updates
6.6 Curium Pharmaceuticals
6.6.1 Curium Pharmaceuticals Corporation Information
6.6.2 Curium Pharmaceuticals Description and Business Overview
6.6.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product Portfolio
6.6.5 Curium Pharmaceuticals Recent Developments/Updates
6.7 Jubilant Radiopharma
6.6.1 Jubilant Radiopharma Corporation Information
6.6.2 Jubilant Radiopharma Description and Business Overview
6.6.3 Jubilant Radiopharma Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jubilant Radiopharma Therapeutic Radiopharmaceuticals Product Portfolio
6.7.5 Jubilant Radiopharma Recent Developments/Updates
6.8 Lantheus
6.8.1 Lantheus Corporation Information
6.8.2 Lantheus Description and Business Overview
6.8.3 Lantheus Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lantheus Therapeutic Radiopharmaceuticals Product Portfolio
6.8.5 Lantheus Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Corporation Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Aurobindo Pharma Therapeutic Radiopharmaceuticals Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 International Isotopes
6.10.1 International Isotopes Corporation Information
6.10.2 International Isotopes Description and Business Overview
6.10.3 International Isotopes Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.10.4 International Isotopes Therapeutic Radiopharmaceuticals Product Portfolio
6.10.5 International Isotopes Recent Developments/Updates
6.11 Mundipharma
6.11.1 Mundipharma Corporation Information
6.11.2 Mundipharma Therapeutic Radiopharmaceuticals Description and Business Overview
6.11.3 Mundipharma Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mundipharma Therapeutic Radiopharmaceuticals Product Portfolio
6.11.5 Mundipharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic Radiopharmaceuticals Industry Chain Analysis
7.2 Therapeutic Radiopharmaceuticals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic Radiopharmaceuticals Production Mode & Process
7.4 Therapeutic Radiopharmaceuticals Sales and Marketing
7.4.1 Therapeutic Radiopharmaceuticals Sales Channels
7.4.2 Therapeutic Radiopharmaceuticals Distributors
7.5 Therapeutic Radiopharmaceuticals Customers
8 Therapeutic Radiopharmaceuticals Market Dynamics
8.1 Therapeutic Radiopharmaceuticals Industry Trends
8.2 Therapeutic Radiopharmaceuticals Market Drivers
8.3 Therapeutic Radiopharmaceuticals Market Challenges
8.4 Therapeutic Radiopharmaceuticals Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Therapeutic Radiopharmaceuticals Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Therapeutic Radiopharmaceuticals Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Therapeutic Radiopharmaceuticals Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Therapeutic Radiopharmaceuticals Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Therapeutic Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Therapeutic Radiopharmaceuticals Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Therapeutic Radiopharmaceuticals Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Therapeutic Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Therapeutic Radiopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Therapeutic Radiopharmaceuticals, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Therapeutic Radiopharmaceuticals, Product Type & Application
    Table 12. Global Key Manufacturers of Therapeutic Radiopharmaceuticals, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Therapeutic Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Radiopharmaceuticals as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Therapeutic Radiopharmaceuticals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Therapeutic Radiopharmaceuticals Sales by Region (2019-2024) & (K Units)
    Table 18. Global Therapeutic Radiopharmaceuticals Sales Market Share by Region (2019-2024)
    Table 19. Global Therapeutic Radiopharmaceuticals Sales by Region (2025-2030) & (K Units)
    Table 20. Global Therapeutic Radiopharmaceuticals Sales Market Share by Region (2025-2030)
    Table 21. Global Therapeutic Radiopharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2019-2024)
    Table 23. Global Therapeutic Radiopharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2025-2030)
    Table 25. North America Therapeutic Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Therapeutic Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
    Table 27. North America Therapeutic Radiopharmaceuticals Sales by Country (2025-2030) & (K Units)
    Table 28. North America Therapeutic Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Therapeutic Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Therapeutic Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Therapeutic Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Therapeutic Radiopharmaceuticals Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Therapeutic Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Therapeutic Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Therapeutic Radiopharmaceuticals Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Therapeutic Radiopharmaceuticals Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Therapeutic Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Therapeutic Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Therapeutic Radiopharmaceuticals Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Therapeutic Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Therapeutic Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Therapeutic Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Therapeutic Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Therapeutic Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Therapeutic Radiopharmaceuticals Sales (K Units) by Type (2019-2024)
    Table 51. Global Therapeutic Radiopharmaceuticals Sales (K Units) by Type (2025-2030)
    Table 52. Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2019-2024)
    Table 53. Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2025-2030)
    Table 54. Global Therapeutic Radiopharmaceuticals Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Therapeutic Radiopharmaceuticals Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2019-2024)
    Table 57. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2025-2030)
    Table 58. Global Therapeutic Radiopharmaceuticals Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Therapeutic Radiopharmaceuticals Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Therapeutic Radiopharmaceuticals Sales (K Units) by Application (2019-2024)
    Table 61. Global Therapeutic Radiopharmaceuticals Sales (K Units) by Application (2025-2030)
    Table 62. Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2019-2024)
    Table 63. Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2025-2030)
    Table 64. Global Therapeutic Radiopharmaceuticals Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Therapeutic Radiopharmaceuticals Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2019-2024)
    Table 67. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2025-2030)
    Table 68. Global Therapeutic Radiopharmaceuticals Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Therapeutic Radiopharmaceuticals Price (USD/Unit) by Application (2025-2030)
    Table 70. Bayer Corporation Information
    Table 71. Bayer Description and Business Overview
    Table 72. Bayer Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Bayer Therapeutic Radiopharmaceuticals Product
    Table 74. Bayer Recent Developments/Updates
    Table 75. Novartis Corporation Information
    Table 76. Novartis Description and Business Overview
    Table 77. Novartis Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Novartis Therapeutic Radiopharmaceuticals Product
    Table 79. Novartis Recent Developments/Updates
    Table 80. China Isotope & Radiation Corporation Information
    Table 81. China Isotope & Radiation Description and Business Overview
    Table 82. China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. China Isotope & Radiation Therapeutic Radiopharmaceuticals Product
    Table 84. China Isotope & Radiation Recent Developments/Updates
    Table 85. Dongcheng Corporation Information
    Table 86. Dongcheng Description and Business Overview
    Table 87. Dongcheng Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Dongcheng Therapeutic Radiopharmaceuticals Product
    Table 89. Dongcheng Recent Developments/Updates
    Table 90. Q BioMed Corporation Information
    Table 91. Q BioMed Description and Business Overview
    Table 92. Q BioMed Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Q BioMed Therapeutic Radiopharmaceuticals Product
    Table 94. Q BioMed Recent Developments/Updates
    Table 95. Curium Pharmaceuticals Corporation Information
    Table 96. Curium Pharmaceuticals Description and Business Overview
    Table 97. Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product
    Table 99. Curium Pharmaceuticals Recent Developments/Updates
    Table 100. Jubilant Radiopharma Corporation Information
    Table 101. Jubilant Radiopharma Description and Business Overview
    Table 102. Jubilant Radiopharma Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Jubilant Radiopharma Therapeutic Radiopharmaceuticals Product
    Table 104. Jubilant Radiopharma Recent Developments/Updates
    Table 105. Lantheus Corporation Information
    Table 106. Lantheus Description and Business Overview
    Table 107. Lantheus Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Lantheus Therapeutic Radiopharmaceuticals Product
    Table 109. Lantheus Recent Developments/Updates
    Table 110. Aurobindo Pharma Corporation Information
    Table 111. Aurobindo Pharma Description and Business Overview
    Table 112. Aurobindo Pharma Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Aurobindo Pharma Therapeutic Radiopharmaceuticals Product
    Table 114. Aurobindo Pharma Recent Developments/Updates
    Table 115. International Isotopes Corporation Information
    Table 116. International Isotopes Description and Business Overview
    Table 117. International Isotopes Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. International Isotopes Therapeutic Radiopharmaceuticals Product
    Table 119. International Isotopes Recent Developments/Updates
    Table 120. Mundipharma Corporation Information
    Table 121. Mundipharma Description and Business Overview
    Table 122. Mundipharma Therapeutic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 123. Mundipharma Therapeutic Radiopharmaceuticals Product
    Table 124. Mundipharma Recent Developments/Updates
    Table 125. Key Raw Materials Lists
    Table 126. Raw Materials Key Suppliers Lists
    Table 127. Therapeutic Radiopharmaceuticals Distributors List
    Table 128. Therapeutic Radiopharmaceuticals Customers List
    Table 129. Therapeutic Radiopharmaceuticals Market Trends
    Table 130. Therapeutic Radiopharmaceuticals Market Drivers
    Table 131. Therapeutic Radiopharmaceuticals Market Challenges
    Table 132. Therapeutic Radiopharmaceuticals Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Therapeutic Radiopharmaceuticals
    Figure 2. Global Therapeutic Radiopharmaceuticals Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Therapeutic Radiopharmaceuticals Market Share by Type in 2023 & 2030
    Figure 4. Radium-223 Product Picture
    Figure 5. Lutetium-177 Product Picture
    Figure 6. Iodine-131 Product Picture
    Figure 7. Other Product Picture
    Figure 8. Global Therapeutic Radiopharmaceuticals Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Therapeutic Radiopharmaceuticals Market Share by Application in 2023 & 2030
    Figure 10. Thyroid
    Figure 11. Bone Metastasis
    Figure 12. Lymphoma
    Figure 13. Other
    Figure 14. Global Therapeutic Radiopharmaceuticals Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Therapeutic Radiopharmaceuticals Market Size (2019-2030) & (US$ Million)
    Figure 16. Global Therapeutic Radiopharmaceuticals Sales (2019-2030) & (K Units)
    Figure 17. Global Therapeutic Radiopharmaceuticals Average Price (USD/Unit) & (2019-2030)
    Figure 18. Therapeutic Radiopharmaceuticals Report Years Considered
    Figure 19. Therapeutic Radiopharmaceuticals Sales Share by Manufacturers in 2023
    Figure 20. Global Therapeutic Radiopharmaceuticals Revenue Share by Manufacturers in 2023
    Figure 21. The Global 5 and 10 Largest Therapeutic Radiopharmaceuticals Players: Market Share by Revenue in 2023
    Figure 22. Therapeutic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 23. Global Therapeutic Radiopharmaceuticals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 24. North America Therapeutic Radiopharmaceuticals Sales Market Share by Country (2019-2030)
    Figure 25. North America Therapeutic Radiopharmaceuticals Revenue Market Share by Country (2019-2030)
    Figure 26. U.S. Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Canada Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Europe Therapeutic Radiopharmaceuticals Sales Market Share by Country (2019-2030)
    Figure 29. Europe Therapeutic Radiopharmaceuticals Revenue Market Share by Country (2019-2030)
    Figure 30. Germany Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. France Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. U.K. Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Italy Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Russia Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Therapeutic Radiopharmaceuticals Sales Market Share by Region (2019-2030)
    Figure 36. Asia Pacific Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2019-2030)
    Figure 37. China Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Japan Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. South Korea Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. India Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Taiwan Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Indonesia Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Thailand Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Malaysia Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Philippines Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Latin America Therapeutic Radiopharmaceuticals Sales Market Share by Country (2019-2030)
    Figure 48. Latin America Therapeutic Radiopharmaceuticals Revenue Market Share by Country (2019-2030)
    Figure 49. Mexico Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Brazil Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Argentina Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Middle East & Africa Therapeutic Radiopharmaceuticals Sales Market Share by Country (2019-2030)
    Figure 53. Middle East & Africa Therapeutic Radiopharmaceuticals Revenue Market Share by Country (2019-2030)
    Figure 54. Turkey Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. U.A.E Therapeutic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. Global Sales Market Share of Therapeutic Radiopharmaceuticals by Type (2019-2030)
    Figure 58. Global Revenue Market Share of Therapeutic Radiopharmaceuticals by Type (2019-2030)
    Figure 59. Global Therapeutic Radiopharmaceuticals Price (USD/Unit) by Type (2019-2030)
    Figure 60. Global Sales Market Share of Therapeutic Radiopharmaceuticals by Application (2019-2030)
    Figure 61. Global Revenue Market Share of Therapeutic Radiopharmaceuticals by Application (2019-2030)
    Figure 62. Global Therapeutic Radiopharmaceuticals Price (USD/Unit) by Application (2019-2030)
    Figure 63. Therapeutic Radiopharmaceuticals Value Chain
    Figure 64. Therapeutic Radiopharmaceuticals Production Process
    Figure 65. Channels of Distribution (Direct Vs Distribution)
    Figure 66. Distributors Profiles
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Non-Steroidal Anti-Inflammatory Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-15D14305
Sun Oct 06 00:00:00 UTC 2024

Add to Cart

Global Chemical Lipid-Lowering Drug Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-31E15198
Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Silicone Scar Repair Sticker Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-22L14432
Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Skin Sealing Surgical Tissue Adhesive Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9B15402
Fri Oct 04 00:00:00 UTC 2024

Add to Cart